Pryor Medical Devices

Prytime Medical Devices, Inc. is an innovative medical device company that designs, develops, and commercializes minimally invasive solutions for hemorrhage control. The company's flagship product is the ER-REBOA™ catheter, a 7 Fr compatible balloon catheter specifically designed for rapid, temporary occlusion of large vessels during REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) in emergency and critical care settings. The foundational intellectual property of the ER-REBOA™ was conceived by experienced military vascular and trauma surgeons, Colonel Todd Rasmussen and Dr. Jonathan Eliason, based on lessons learned from frontline combat experience. The first wire-free prototype was developed and tested in animals in 2011. Shortly thereafter, the company was founded. In October 2015, the ER-REBOA™ catheter received 510(k) clearance, and commercialization of the device began in 2016, followed by entry into the European market. Now approved in Canada as well, the use of the device is expanding worldwide, with the total number of hospitals using the ER-REBOA™ catheter now exceeding 250. The initial market for the device is trauma, with strong traction in adjacent markets including cardiac arrest, postpartum hemorrhage, interventional radiology, inpatient, and pre-hospital care. At Prytime, we are proud to be part of bringing military medical innovations to the civilian market.